- Home
- LW vs BBIO Comparison
LW vs BBIO Comparison
Compare LW & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LW
- BBIO
- Stock Information
- Founded
- LW 1950
- BBIO 2015
- Country
- LW United States
- BBIO United States
- Employees
- LW N/A
- BBIO N/A
- Industry
- LW Packaged Foods
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LW Consumer Staples
- BBIO Health Care
- Exchange
- LW Nasdaq
- BBIO Nasdaq
- Market Cap
- LW 9.0B
- BBIO 10.4B
- IPO Year
- LW N/A
- BBIO 2019
- Fundamental
- Price
- LW $65.57
- BBIO $64.50
- Analyst Decision
- LW Buy
- BBIO Strong Buy
- Analyst Count
- LW 10
- BBIO 16
- Target Price
- LW $69.40
- BBIO $65.88
- AVG Volume (30 Days)
- LW 2.0M
- BBIO 2.2M
- Earning Date
- LW 12-18-2025
- BBIO 10-29-2025
- Dividend Yield
- LW 2.26%
- BBIO N/A
- EPS Growth
- LW N/A
- BBIO N/A
- EPS
- LW 2.08
- BBIO N/A
- Revenue
- LW $6,456,500,000.00
- BBIO $235,812,000.00
- Revenue This Year
- LW $4.12
- BBIO $115.12
- Revenue Next Year
- LW N/A
- BBIO $65.29
- P/E Ratio
- LW $31.56
- BBIO N/A
- Revenue Growth
- LW 0.00
- BBIO 7.62
- 52 Week Low
- LW $47.87
- BBIO $21.72
- 52 Week High
- LW $83.98
- BBIO $65.00
- Technical
- Relative Strength Index (RSI)
- LW 64.53
- BBIO 74.99
- Support Level
- LW $63.54
- BBIO $52.75
- Resistance Level
- LW $67.07
- BBIO $65.00
- Average True Range (ATR)
- LW 1.37
- BBIO 2.11
- MACD
- LW -0.08
- BBIO 0.68
- Stochastic Oscillator
- LW 67.11
- BBIO 95.92
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.